Terry Smith
Fundsmith · 13F for the quarter to 30 June 2026, filed 14 August 2026
- Portfolio
- $13.6B
- Stocks
- 41
- Largest
- MAR
Portfolio
As of 30 June 2026. The change is in shares, against the 13F for 31 March 2026; a stock split is taken out. Read the 13F
| Stock | Weight | Value | Shares | Change |
|---|---|---|---|---|
| 7.0% | $958.3M | 2,585,757 | -23% | |
| 6.7% | $917.4M | 2,913,833 | -5% | |
| 6.2% | $852.7M | 2,273,632 | -29% | |
| 5.1% | $693.0M | 2,019,810 | -35% | |
| 4.7% | $645.3M | 8,943,151 | New position |
Every holding and move is free with an account
Sign up freeMoves since the 13F
Form 4 trades in companies where the firm is an insider, and Schedules 13D and 13G, filed once a stake passes 5%.
Nothing filed since the 13F.
Sold out during the quarter
| Stock | Weight | Value | Shares |
|---|---|---|---|
| 5.6% | $717.0M | 568,516 | |
| 3.6% | $458.4M | 3,877,559 | |
| 1.6% | $210.6M | 2,731,635 | |
| Catalyst Pharmaceuticals Inc | 0.2% | $20.9M | 844,887 |
| 0.2% | $19.9M | 226,077 |
Every holding and move is free with an account
Sign up freeSource: Form 13F, Form 4 and Schedules 13D and 13G filed with the SEC. A 13F lists US-listed shares only (no short positions, no cash, no holdings abroad); options and bonds are left out here. Values are at the quarter's end, as the firm reported them. Super investor portfolios